Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing [Yahoo! Finance]
Immunome, Inc. (IMNM)
Company Research
Source: Yahoo! Finance
On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome (NASDAQ:IMNM) , an estimated $37.30 million trade based on quarterly average pricing. What Happened According to its SEC filing dated February 17, 2026, Opaleye Management Inc. sold all 3,185,000 shares of Immunome during the fourth quarter of 2025. The estimated transaction value is $37.30 million, based on the average share price over the quarter. This move resulted in the fund holding no remaining shares of Immunome at the end of the reporting period. The quarter-end position value dropped by $37.30 million, reflecting the stake's full removal. What Else to Know The fund exited its Immunome position, which previously represented 5.3% of 13F assets under management; following the transaction, Immunome accounts for none of the portfolio (percent of AUM: n/a). Top holdings following the filing: NASDAQ:HROW: $191.34 million (25.2% of AUM) NASDAQ:LQDA: $84.98 million (11.2% of
Show less
Read more
Impact Snapshot
Event Time:
IMNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNM alerts
High impacting Immunome, Inc. news events
Weekly update
A roundup of the hottest topics
IMNM
News
- Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Immunome (IMNM) had its price target raised by Craig Hallum from $33.00 to $36.00. They now have a "buy" rating on the stock.MarketBeat
- Immunome (IMNM) had its price target lowered by Stephens from $33.00 to $30.00. They now have an "overweight" rating on the stock.MarketBeat
- Immunome Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Immunome Reports Full Year 2025 Financial Results and Provides Business UpdateBusiness Wire
IMNM
Earnings
- 8/6/25 - Beat
IMNM
Sec Filings
- 3/3/26 - Form S-8
- 3/3/26 - Form 10-K
- 3/3/26 - Form 8-K
- IMNM's page on the SEC website